title: Words of wisdom. Re: Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma.
authors.affiliation: Prostate Cancer Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors.forename: Maha
authors.initials: M
authors.lastname: Hussain
authors.affiliation: University of Colorado Comprehensive Cancer Center, Aurora, CO, USA. Electronic address: dan.theodorescu@ucdenver.edu.
authors.forename: Dan
authors.initials: D
authors.lastname: Theodorescu
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D017239:Paclitaxel